MedTrace Logo

Statins in Reducing Events in the Elderly Mind (STAREE-Mind) Imaging Substudy

NCT05586750 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 341

Last updated 2025-05-22

No results posted yet for this study

Summary

The STAREE-Mind imaging sub-study will examine the effect of statin treatment over a 4-year period, compared with placebo, on markers of brain health.

Conditions

Interventions

DRUG

Atorvastatin 40 Mg Oral Tablet

40 mg atorvastatin (2 x 20 mg atorvastatin daily), taken orally

DRUG

Placebo

2 x 20mg placebo (daily), taken orally. Identical appearance to study drug

Sponsors & Collaborators

  • National Health and Medical Research Council, Australia

    collaborator OTHER

  • Monash University

    lead OTHER

Principal Investigators

  • Sophia Zoungas, MBBS, FRACP · Monash University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-19
Primary Completion
2026-09-30
Completion
2026-09-30

Countries

  • Australia

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05586750 on ClinicalTrials.gov